MedPath

江苏正大清江制药有限公司

Ownership
-
Established
2001-02-28
Employees
-
Market Cap
-
Website
https://www.ctqjph.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

75

NMPA:75

Drug Approvals

Methocarbamol Injection

Product Name
美索巴莫注射液
Approval Number
国药准字H20254255
Approval Date
May 27, 2025
NMPA

Procaterol Hydrochloride Granules

Product Name
盐酸丙卡特罗颗粒
Approval Number
国药准字H20254102
Approval Date
May 13, 2025
NMPA

Ornidazole Injection

Product Name
奥硝唑注射液
Approval Number
国药准字H20249261
Approval Date
Nov 5, 2024
NMPA

Ornidazole Injection

Product Name
奥硝唑注射液
Approval Number
国药准字H20249260
Approval Date
Nov 5, 2024
NMPA

Oseltamivir Phosphate for Suspension

Product Name
磷酸奥司他韦干混悬剂
Approval Number
国药准字H20244748
Approval Date
Aug 27, 2024
NMPA

Iguratimod Tablets

Product Name
艾拉莫德片
Approval Number
国药准字H20244320
Approval Date
Jun 28, 2024
NMPA

Rocuronium Bromide Injection

Product Name
罗库溴铵注射液
Approval Number
国药准字H20243987
Approval Date
Jun 11, 2024
NMPA

Apremilast Tablets

Product Name
阿普米司特片
Approval Number
国药准字H20233834
Approval Date
Jun 30, 2023
NMPA

Apremilast Tablets

Product Name
阿普米司特片
Approval Number
国药准字H20233835
Approval Date
Jun 30, 2023
NMPA

Apremilast Tablets

Product Name
阿普米司特片
Approval Number
国药准字H20233836
Approval Date
Jun 30, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.